Resistance to FDA’s opioid-disposal plan raises concerns about CADCA, a powerful advocacy group

At its surface, it seems like a simple problem with a simple solution. Across the country, medicine cabinets are littered with unused, potentially addictive opioids. So the federal government wants to distribute prepaid envelopes alongside new painkiller prescriptions, allowing Americans to mail back their leftovers.

But the seemingly innocuous proposal has generated opposition from a surprising source: the Community Anti-Drug Coalitions of America, a powerful nonprofit organization that has dominated drug policy advocacy in Washington for decades.